Ralph Laufer
Chief Tech/Sci/R&D Officer bei LYSOGENE
Profil
Ralph Laufer is currently the Chief Scientific Officer at Lysogene SA since 2018.
Prior to this, he was the Senior Vice President at Teva Pharmaceutical Industries Ltd.
from 2013 to 2018.
He was also the Scientific Director at IRBM Science Park SpA from 2001 to 2009 and the Head-Pharmacology at IRBM SpA from 1991 to 2001.
Additionally, he worked as a Director at Immuneering Corp.
Dr. Laufer received his graduate and doctorate degrees from The Hebrew University of Jerusalem.
Aktive Positionen von Ralph Laufer
| Unternehmen | Position | Beginn |
|---|---|---|
| LYSOGENE | Chief Tech/Sci/R&D Officer | 02.05.2018 |
Ehemalige bekannte Positionen von Ralph Laufer
| Unternehmen | Position | Ende |
|---|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Corporate Officer/Principal | 01.04.2018 |
IRBM Science Park SpA
 IRBM Science Park SpA Miscellaneous Commercial ServicesCommercial Services IRBM Science Park SpA engages in researching and developing biomedical products. The company is headquartered in Pomezia, Italy. | Chief Tech/Sci/R&D Officer | 01.10.2009 |
IRBM SpA
 IRBM SpA BiotechnologyHealth Technology IRBM SpA is a research organization that specializes in drug discovery and development. IRBM is based in Pomezia, IT, and has subsidiaries in Italy. The Italian company produces recombinant proteins in a homogeneous state and use cyclization to pre-organize compounds for target binding. The private company uses nuclear magnetic resonance (NMR) spectroscopy to study structural biology, clinical research solutions, functional genomics, structure/activity relationships, drug discovery, macromolecule, and small-molecule analysis. The company has a screening library of over 320,000 compounds and use virtual screening and NMR to drive innovation. The company was founded in 2010 by Piero di Lorenzo, who has been the CEO since then. | Corporate Officer/Principal | 01.01.2001 |
| IMMUNEERING CORPORATION | Director/Board Member | - |
Ausbildung von Ralph Laufer
| The Hebrew University of Jerusalem | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 3 |
|---|---|
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Health Technology |
| IMMUNEERING CORPORATION | Health Technology |
| LYSOGENE | Commercial Services |
| Private Unternehmen | 2 |
|---|---|
IRBM SpA
IRBM SpA BiotechnologyHealth Technology IRBM SpA is a research organization that specializes in drug discovery and development. IRBM is based in Pomezia, IT, and has subsidiaries in Italy. The Italian company produces recombinant proteins in a homogeneous state and use cyclization to pre-organize compounds for target binding. The private company uses nuclear magnetic resonance (NMR) spectroscopy to study structural biology, clinical research solutions, functional genomics, structure/activity relationships, drug discovery, macromolecule, and small-molecule analysis. The company has a screening library of over 320,000 compounds and use virtual screening and NMR to drive innovation. The company was founded in 2010 by Piero di Lorenzo, who has been the CEO since then. | Health Technology |
IRBM Science Park SpA
IRBM Science Park SpA Miscellaneous Commercial ServicesCommercial Services IRBM Science Park SpA engages in researching and developing biomedical products. The company is headquartered in Pomezia, Italy. | Commercial Services |
